1038 related articles for article (PubMed ID: 30422241)
21. Liver resection for large and huge hepatocellular carcinoma: Predictors of failure, recurrence patterns, and prognoses.
Xiang C; Xiao Y; Ma Z; Peng Y; Li X; Mao X; Li L
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e60-e70. PubMed ID: 35404506
[TBL] [Abstract][Full Text] [Related]
22. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
[TBL] [Abstract][Full Text] [Related]
23. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
24. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
25. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
26. Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis.
Gruttadauria S; Pagano D; Corsini LR; Cintorino D; Li Petri S; Calamia S; Seidita A; di Francesco F
Updates Surg; 2020 Mar; 72(1):109-117. PubMed ID: 31625024
[TBL] [Abstract][Full Text] [Related]
27. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
[TBL] [Abstract][Full Text] [Related]
28. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
29. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre.
Grazi GL; Cescon M; Ravaioli M; Ercolani G; Gardini A; Del Gaudio M; Vetrone G; Cavallari A
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():119-29. PubMed ID: 12786623
[TBL] [Abstract][Full Text] [Related]
30. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
[TBL] [Abstract][Full Text] [Related]
31. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
[TBL] [Abstract][Full Text] [Related]
32. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.
Taura K; Ikai I; Hatano E; Fujii H; Uyama N; Shimahara Y
Ann Surg; 2006 Aug; 244(2):265-73. PubMed ID: 16858190
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.
Cheng Z; Yang P; Qu S; Zhou J; Yang J; Yang X; Xia Y; Li J; Wang K; Yan Z; Wu D; Zhang B; Hüser N; Shen F
HPB (Oxford); 2015 May; 17(5):422-7. PubMed ID: 25421805
[TBL] [Abstract][Full Text] [Related]
34. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function.
Kang CM; Choi GH; Kim DH; Choi SB; Kim KS; Choi JS; Lee WJ
J Surg Res; 2010 May; 160(1):81-9. PubMed ID: 19577249
[TBL] [Abstract][Full Text] [Related]
35. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
[TBL] [Abstract][Full Text] [Related]
36. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Young SH; Chau GY; Lee IC; Yeh YC; Chao Y; Huo TI; Su CW; Lin HC; Hou MC; Lee MH; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):218-229. PubMed ID: 31104872
[TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients.
Du ZG; Wei YG; Chen KF; Li B
Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):153-61. PubMed ID: 24686542
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma.
Li T; Qin LX; Gong X; Zhou J; Sun HC; Wang L; Qiu SJ; Ye QH; Fan J
Surgery; 2014 Sep; 156(3):651-60. PubMed ID: 24998159
[TBL] [Abstract][Full Text] [Related]
40. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
